Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
i CluF: an unsupervised iterative cluster-fusion method for patient stratification using multiomics data.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Oxford University Press Country of Publication: England NLM ID: 9918282081306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2635-0041 (Electronic) Linking ISSN: 26350041 NLM ISO Abbreviation: Bioinform Adv Subsets: PubMed not MEDLINE
- بيانات النشر:
Original Publication: [Oxford] : Oxford University Press : International Society for Computational Biology, [2021]-
- نبذة مختصرة :
Motivation: Patient stratification is crucial for the effective treatment or management of heterogeneous diseases, including cancers. Multiomic technologies facilitate molecular characterization of human diseases; however, the complexity of data warrants the need for the development of robust data integration tools for patient stratification using machine-learning approaches.
Results: i CluF iteratively integrates three types of multiomic data (mRNA, miRNA, and DNA methylation) using pairwise patient similarity matrices built from each omic data. The intermediate omic-specific neighborhood matrices implement iterative matrix fusion and message passing among the similarity matrices to derive a final integrated matrix representing all the omics profiles of a patient, which is used to further cluster patients into subtypes. i CluF outperforms other methods with significant differences in the survival profiles of 8581 patients belonging to 30 different cancers in TCGA. i CluF also predicted the four intrinsic subtypes of Breast Invasive Carcinomas with adjusted rand index and Fowlkes-Mallows scores of 0.72 and 0.83, respectively. The Gini importance score showed that methylation features were the primary decisive players, followed by mRNA and miRNA to identify disease subtypes. i CluF can be applied to stratify patients with any disease containing multiomic datasets.
Availability and Implementation: Source code and datasets are available at https://github.com/GudaLab/iCluF_core.
Competing Interests: None declared.
(© The Author(s) 2024. Published by Oxford University Press.)
- References:
Bioinformatics. 2018 Nov 1;34(21):3711-3718. (PMID: 29757357)
Comput Struct Biotechnol J. 2021 Jan 22;19:949-960. (PMID: 33613862)
Front Genet. 2020 Oct 23;11:578345. (PMID: 33193699)
Nat Methods. 2014 Mar;11(3):333-7. (PMID: 24464287)
Nat Commun. 2018 Oct 26;9(1):4453. (PMID: 30367051)
BMC Genomics. 2015 Dec 01;16:1022. (PMID: 26626453)
Bioinformatics. 2017 Feb 1;33(3):458-460. (PMID: 28172495)
Front Genet. 2023 Apr 20;14:1061364. (PMID: 37152984)
Bioinformatics. 2002 Mar;18(3):413-22. (PMID: 11934740)
Bioinformatics. 2015 Jun 15;31(12):i268-75. (PMID: 26072491)
Bioinformatics. 2019 Aug 15;35(16):2843-2846. (PMID: 30590381)
Breast Cancer Res. 2020 Jan 28;22(1):12. (PMID: 31992350)
PLoS One. 2013 May 21;8(5):e64268. (PMID: 23704984)
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6143-51. (PMID: 15448001)
Bioinformatics. 2010 Jun 15;26(12):1572-3. (PMID: 20427518)
Bioinformatics. 2005 Nov 1;21(21):3970-5. (PMID: 16244221)
Biomed Res Int. 2019 Aug 27;2019:2426958. (PMID: 31534955)
Wiley Interdiscip Rev Comput Stat. 2022 May-Jun;14(3):. (PMID: 35573155)
Front Genet. 2022 Mar 22;13:854752. (PMID: 35391796)
Front Bioinform. 2022 Jun 27;2:927312. (PMID: 36304293)
PLoS One. 2017 May 1;12(5):e0176278. (PMID: 28459819)
PLoS One. 2018 Aug 20;13(8):e0202167. (PMID: 30125332)
Comput Biol Med. 2023 Jul;161:106988. (PMID: 37201441)
Sci Rep. 2021 Oct 26;11(1):21071. (PMID: 34702958)
J Natl Cancer Inst. 2014 Dec 04;107(1):357. (PMID: 25479802)
Bioinformatics. 2009 Nov 15;25(22):2906-12. (PMID: 19759197)
Front Oncol. 2020 Jun 24;10:1052. (PMID: 32714868)
Bioinformatics. 2012 Dec 15;28(24):3290-7. (PMID: 23047558)
Bioinformatics. 2004 Nov 1;20(16):2605-17. (PMID: 15130935)
Breast Cancer Res Treat. 2023 May;199(1):1-12. (PMID: 36867282)
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4245-50. (PMID: 23431203)
Bioinformatics. 2021 Aug 25;37(16):2231-2237. (PMID: 33599254)
Bioinformatics. 2001 Feb;17(2):126-36. (PMID: 11238068)
PLoS One. 2015 Feb 23;10(2):e0118453. (PMID: 25706888)
Cell. 2018 Apr 5;173(2):291-304.e6. (PMID: 29625048)
NPJ Breast Cancer. 2023 Mar 22;9(1):16. (PMID: 36949047)
Cancer Res Treat. 2019 Apr;51(2):737-747. (PMID: 30189722)
Transl Lung Cancer Res. 2014 Aug;3(4):242-9. (PMID: 25806307)
Genome Res. 2017 Dec;27(12):2025-2039. (PMID: 29066617)
Front Oncol. 2021 Dec 01;11:769447. (PMID: 34926274)
Metabolites. 2020 May 15;10(5):. (PMID: 32429287)
Genes (Basel). 2022 Aug 25;13(9):. (PMID: 36140696)
- الموضوع:
Date Created: 20240503 Latest Revision: 20240504
- الموضوع:
20250114
- الرقم المعرف:
PMC11063539
- الرقم المعرف:
10.1093/bioadv/vbae015
- الرقم المعرف:
38698887
No Comments.